From: POLE2 knockdown reduce tumorigenesis in esophageal squamous cells
Features | No. of patients | POLE2 expression | P value | ||
---|---|---|---|---|---|
Low | High | ||||
All patients | 101 | 41 | 60 | Â | |
Age (years) | 0.601 | ||||
 ≤ 65 | 51 | 22 | 29 |  | |
 > 65 | 50 | 19 | 31 |  | |
Gender | 0.040* | ||||
 Male | 75 | 26 | 49 |  | |
 Female | 26 | 15 | 11 |  | |
Lymph node positive | 0.100 | ||||
 ≤ 1 | 52 | 24 | 28 |  | |
 > 1 | 38 | 11 | 27 |  | |
Tumor size (cm) | 0.757 | ||||
 < 5 | 41 | 16 | 25 |  | |
 ≥ 5 | 42 | 15 | 27 |  | |
Grade | 0.635 | ||||
 I | 8 | 3 | 5 |  | |
 II | 66 | 26 | 40 |  | |
 III | 27 | 12 | 15 |  | |
AJCC stage | 0.002** | ||||
 1 | 4 | 2 | 2 |  | |
 2 | 42 | 25 | 17 |  | |
 3 | 50 | 13 | 37 |  | |
T infiltrate | 0.623 | ||||
 T1 | 4 | 2 | 2 |  | |
 T2 | 11 | 5 | 6 |  | |
 T3 | 80 | 33 | 47 |  | |
 T4 | 3 | 1 | 2 |  | |
Lymphatic metastasis (N) | 0.006** | ||||
 N0 | 45 | 26 | 19 |  | |
 N1 | 30 | 7 | 23 |  | |
 N2 | 19 | 6 | 13 |  | |
 N3 | 4 | 1 | 3 |  |